Original articleWomen and mexican Americans receive fewer cardiovascular drugs following myocardial infarction than men and non-hispanic whites: The Corpus Christi Heart Project, 1988–1990☆
References (42)
Secondary prevention after myocardial infarction
Lancet
(1986)- et al.
Hospitalization rates for myocardial infarction among Mexican Americans and non-Hispanic whites: the Corpus Christi Heart Project
Ann Epidemiol
(1993) - et al.
International diagnostic criteria for acute myocardial infarction and acute stroke
Am Heart J
(1984) The secondary prevention of myocardial infarction by drug treatments, excluding lipid-lowering agents
Clin Exp Hypertens
(1992)Secondary prevention in myocardial infarction survivors
Circulation
(1980)Secondary prevention after myocardial infarction: facts and fallacies
J Cardiovasc Pharmacol
(1984)- et al.
Risk factor modification after myocardial infarction
Ann Int Med
(1988) The case for beta-blockers as first-line antihypertensive therapy (suppl)
J Hypertens
(1992)- et al.
Noninvasive and invasive strategies for the prevention of sudden death after myocardial infarction. Value, limitations and implications for therapy
Drugs
(1992) - et al.
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction—results of the Survival and Ventricular Enlargement Trial
N Engl J Med
(1992)
Effect of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril survival Study (CONSENSUS)
N Engl J Med
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
N Engl J Med
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
N Engl J Med
Prevention of myocardial infarction
Am J Cardiol
Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults
Arch Intern Med
The cholesterol facts: a summary of evidence relating dietary fats, serum cholesterol, and coronary heart disease: a joint statement by the American Heart Association and the National Heart, Lung and Blood Institute
Circulation
Overview of results of randomized clinical trials in heart disease. II) Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification
JAMA
Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall Study
Brit Med J
The value of lowering cholesterol after myocardial infarction
N Engl J Med
Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary disease
N Engl J Med
Cited by (42)
Addressing challenges faced by underrepresented biomedical investigators and efforts to address them: An NHLBI-PRIDE perspective
2022, Journal of the National Medical AssociationCitation Excerpt :Health disparities may be due in part to disparities in access to care. For instance, Hispanic individuals were found to be less likely to receive cardiac medications after myocardial infarction,13 and discharge instructions.14 Black patients are less likely to have coronary artery bypass surgery,15 or receive care by a cardiologist when being treated for heart failure in the intensive care unit.16
Social vulnerability, medical care access and asthma related emergency department visits and hospitalization: An observational study
2022, Heart and LungCitation Excerpt :Although some physicians may show less care to low socioeconomic patients due to reduced reimbursement rates, others consider tailoring the treatment plan is the best way to ensure compliance and avoid financial or coverage issues.56-59 Akin to that, minority status showed similar disparities where African Americans found to have higher rates of undesirable procedures (e.g. amputations), perceived more negatively by pysicians, and higher overall mortality rates than Whites.54,60-66 Thus, this study is an important addition to emphasize that asthma-related intervention should go beyond clinical intervention and focus on studying existing disparity along with upstreaming populational level social determinants of health at research, policy, and implementational level.
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
2009, Journal of the American College of CardiologyCitation Excerpt :Yet, most large, multicenter trials have not included sufficient numbers of women to allow conclusions about the efficacy and safety of their treatment. Several studies have documented a lower use of ACEIs in women with HF than in men (628), and another study reported that women are given fewer cardiovascular medications after an MI than men (564,629,630). These findings may explain why women have been noted to rate their quality of inpatient care lower than men and why they have less improvement in physical health status after an episode of HF (564).
Are there sex-related differences in specialized, multidisciplinary congestive heart failure clinics?
2007, Canadian Journal of CardiologyACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure)
2005, Journal of the American College of CardiologyRecent and temporal trends (1975 to 1999) in the treatment, hospital, and long-term outcomes of Hispanic and non-Hispanic white patients hospitalized with acute myocardial infarction: A population-based perspective
2004, American Heart JournalCitation Excerpt :There was a marked increase in the hospital use of β-blockers over time in both race/ethnic groups. Underuse of β-blockers among Hispanics has been previously reported.2,24,26 In terms of the use of lipid-lowering therapy, our study suggests that Hispanics are slightly less likely to be treated with this regimen.
- ☆
This investigation was supported by Grant Number HL38429, awarded by the National Heart, Lung, and Blood Institute, and by a grant awarded by the German Academic Exchange Service (DAAD), Bonn, Germany.